## Abstract ## Background and Objectives Photosan^®^, a mixture of porphyrin oligomers as sensitizer for photodynamic therapy (PDT), carry the risk of prolonged photosensitivity of the skin. New sensitizer such as 5‐aminolaevulinic acid (ALA) with low rates of skin phototoxicity appear to be promi
Development of a Stable Solution of 5-Aminolaevulinic Acid for Intracutaneous Injection in Photodynamic Therapy
✍ Scribed by A.W. de Blois; R.J.E. Grouls; E.W. Ackerman; W.J.A. Wijdeven
- Publisher
- Springer-Verlag
- Year
- 2002
- Tongue
- English
- Weight
- 113 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0268-8921
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Photodynamic therapy (PDT) using topical 5‐aminolaevulinic acid (ALA) has been used to treat histologically confirmed cervical intraepithelial neoplasia (CIN‐I and ‐I/II) in a randomised, double‐blind, placebo‐controlled protocol. Fluorescence microscopy revealed that topical applicatio
5-aminolevulanic acid (ALA), belonging among the promising second generation of sensitizers, was evaluated as an inducer of photodamage on HeLa (human cervical adenocarcinoma) cell line. A diode laser (635 nm) was used as a source for initiation of the photodynamic effect. We studied the influence o